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When medical researchers test a new treatment procedure, they recruit patients with ap-
propriate health problems and medical histories. An experiment with a new procedure is
called a clinical trial. The selection of patients for clinical trials has traditionally been a
labor-intensive task, which involves matching of medical records with a list of eligibility
criteria.
A recent project at the University of South Florida has been aimed at the automation
of this task. The project has involved the development of an expert system that selects
matching clinical trials for each patient. If a patient’s data are not sufficient for choosing a
trial, the system suggests additional medical tests.
We report the work on the representation and entry of the related selection criteria
and medical tests. We first explain the structure of the system’s knowledge base, which
describes clinical trials and criteria for selecting patients. We then present an interface that
enables a clinician to add new trials and selection criteria without the help of a programmer.
Experiments show that the addition of a new clinical trial takes ten to twenty minutes, and
that novice users learn the full functionality of the interface in about an hour.
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Chapter 1
Introduction
Cancer causes 550,000 deaths in the United States every year [Keppel et al., 2002], and
the treatment of cancer is an active research area. Medical experts explore new treatment
methods, including drugs, surgery techniques, radiation therapies, and gene therapies. An
experiment with a new treatment procedure is called a clinical trial. When researchers
test a new procedure, they choose subjects with an appropriate cancer type and medical
history. The selection of subjects has traditionally been a manual procedure, which involves
significant human effort, and clinicians often miss eligible patients [Yusuf et al., 1990;
Kotwall et al., 1992; Tu et al., 1993; Se´roussi et al., 1999a; Gennari and Reddy, 2000].
A recent project at the University of South Florida has been aimed at automatic se-
lection of patients for clinical trials. Fletcher and her colleagues have developed an expert
system that prompts a clinician for a patient’s data and identifies all matching trials [Bhanja
et al., 1998]. Experiments have shown that the system improves the matching accuracy and
reduces human effort. Kokku et al. [2002a] have added a mechanism for ordering related
medical tests; its purpose is to minimize the cost of tests involved in the selection process.
The system includes a knowledge base with information about available clinical tri-
als, criteria for selecting patients, and related medical tests. When introducing new trials,
clinicians need to add them to the knowledge base. Fletcher did not provide an interface
for adding new trials, and she encoded the eligibility criteria in a special programming
language. The time required to add a new trial varied from twenty to thirty hours. The
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language did not enforce standard encoding, and two programmers could produce incom-
patible descriptions of eligibility criteria.
We have designed a web-based interface that enables a clinician to add new trials
without the help of a programmer. It has reduced the entry time from twenty hours to
about twenty minutes. Furthermore, it converts the eligibility criteria into a standardized
form and ensures compatibility of all knowledge in the system. We have used the interface
to build a knowledge base for clinical trials at the Moffitt Cancer Center, located at the
University of South Florida.
We begin with a review of previous work on medical expert systems (Chapter 2). We
then explain the knowledge representation in the developed system (Chapter 3), describe
the interface for adding new knowledge (Chapter 4), and conclude with a summary of the
results and future challenges (Chapter 5).
2
Chapter 2
Previous Work
The automation of medical diagnosis and treatment selection is an important problem, and
computer scientists have developed a variety of medical expert systems. They have cre-
ated rule-based systems and Bayesian networks that capture expertise for several medical
domains, covering bacterial diseases, cancer, asthma, liver diseases, and AIDS. We review
some of these systems (Section 2.1) and related work on knowledge representation and
acquisition (Sections 2.2 and 2.3).
2.1 Expert Systems
Researchers began to work on medical applications of artificial intelligence in the early
seventies. Shortliffe and his colleagues developed the famous MYCIN system, which di-
agnosed bacterial diseases and suggested appropriate therapies [Shortliffe, 1974; Shortliffe
et al., 1975; Buchanan and Shortliffe, 1984]. It evolved from a chemical expert system,
called DENDRAL [Lederberg, 1965; Buchanan et al., 1969; Lederberg, 1987], that deter-
mined molecular structures based on spectrography results.
MYCIN’s knowledge base consisted of if-then rules, which allowed the analysis of
symptoms, selection of therapies, and evaluation of the selection certainty. For example,
the system could determine that a patient with flu needed aspirin with 0.8 certainty. Ex-
periments confirmed that MYCIN correctly diagnosed common diseases, which led to the
development of other medical systems [Buchanan and Shortliffe, 1984; Musen, 1989], such
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as NEOMYCIN, PUFF, CENTAUR, and VM. Shortliffe et al. [1981] created a system for se-
lecting chemotherapy treatments, called ONCOCIN, which also evolved from MYCIN.
Lucas et al. [1989] constructed a rule-based system, called HEPAR, for diagnosing
liver and biliary-tract diseases, but it often gave wrong diagnoses [Korver and Janssens,
1993; Onisko et al., 1997]. Korver and Lucas [1993] converted the initial system into a
Bayesian network, which improved its performance [Lucas, 1994].
Musen et al. [1996] built a rule-based system, called EON, that analyzed dependencies
among the available data and assigned AIDS patients to clinical trials. For example, if an
onset of low blood pressure coincided with the beginning of a new clinical trial, the system
would notice that the trial may have caused the low pressure.
Ohno-Machado et al. [1993] developed the AIDS2 system, which also matched AIDS
patients to clinical trials. They integrated logical rules with Bayesian networks, which
helped to make decisions in the absence of some data and to quantify the certainty of these
decisions.
Bouaud et al. [1998; 2000] created a cancer expert system, called ONCODOC, that
suggested alternative clinical trials for each patient, and allowed a physician to choose
among them. It included a graphical interface for interactive entry of a patient’s data and
consideration of alternative trials. Se´roussi et al. [1999a; 1999b; 2000; 2001a; 2001b] used
ONCODOC to select participants for clinical trials at two hospitals, which helped to increase
the number of selected patients by a factor of three.
Theocharous [1996] developed a Bayesian system that chose clinical trials for cancer
patients. It learned conditional probabilities of medical-test outcomes and used them to
evaluate the probability of a patient’s eligibility for each trial [Papaconstantinou et al.,
1998]. On the negative side, the available medical records were insufficient for learning
accurate probabilities. Furthermore, when a user added new clinical trials, he had to change
the structure of the underlying Bayesian network, which was often a difficult task.
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Hammond and Sergot [1996] built the OaSiS architecture, which combined the tech-
niques from several earlier systems, including ONCOCIN and EON. It had a graphical inter-
face for entering patients’ data and extending the knowledge base.
Fallowfield et al. [1997] studied how physicians selected cancer patients for clinical
trials, and compared manual and automatic selection. They showed that expert systems
could improve the selection accuracy; however, their study also revealed that physicians
were usually reluctant to use these systems. Carlson et al. [1995] conducted similar exper-
iments with choosing participants for AIDS studies, and also concluded that expert systems
could lead to a more accurate selection.
2.2 Knowledge Representation
Researchers have long realized the need for a general-purpose representation of medical
knowledge [Clancey, 1993; Clancey, 1995] and investigated a variety of related represen-
tations.
In particular, Ohno-Machado et al. [1998] proposed a general format for medical
knowledge, called the GuideLine Interchange Format. Their project involved researchers
from Stanford, Harvard, and Columbia; they used the developed representation with a vari-
ety of algorithms, and concluded that it was sufficient for most medical knowledge. On the
negative side, it did not enforce compatibility among knowledge bases developed by differ-
ent researchers. Furthermore, it needed major improvements for representing conditional
expressions, temporal reasoning, and uncertainty.
Lindberg et al. [1993] proposed an alternative general-purpose format, called the
Unified Medical Language System, and developed tools for converting various medical
databases into this format. Later, Le Duff et al. [2000] studied techniques for translating
natural-language description of diseases into Lindberg’s representation.
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Rubin et al. [1999; 2000] analyzed selection criteria for clinical trials related to three
cancer types and proposed a format for these criteria. They built a mechanism for en-
coding new criteria, which helped the users to avoid simple mistakes, such as missing or
inconsistent selection rules.
Wang et al. [2001] compared eight previously developed formats and identified main
elements of medical knowledge, which included patient data, treatment decisions, related
actions, and a global state of an expert system. Wang also pointed out the need for abstrac-
tion and temporal reasoning.
2.3 Knowledge Acquisition
Early expert systems did not include knowledge-acquisition tools, and programmers hand-
coded the related rules. To simplify knowledge entry, researchers implemented specialized
tools for some systems. For example, Musen et al. [1988; 1989] developed the OPAL sys-
tem for adding new knowledge to ONCOCIN, and Marcus and McDermott [1989] built the
SALT system, which helped engineers to specify rules for elevator design.
Eriksson [1993] pointed out the need for general-purpose tools that would allow ef-
ficient knowledge acquisition, and described a system for building such tools. Tallis and
his colleagues developed a library of scripts for modifying knowledge bases, which helped
to enforce the consistency of the modified knowledge [Gil and Tallis, 1997; Tallis, 1998;
Tallis and Gil, 1999; Tallis et al., 1999]. Kim and Gil [2000a; 2000b] considered the use of
scripts for building new knowledge-acquisition tools, and created a system for evaluating
these tools. Blythe et al. [2001] designed a general knowledge-acquisition interface based
on previous techniques.
Musen and his colleagues developed the PROTE´GE´ environment for creating knowl-
edge bases [Musen, 1989]; later, researchers used it in the work on AIDS expert sys-
tems [Puerta et al., 1992a; Puerta et al., 1992b], asthma treatment selection [Johnson and
6
Musen, 1996], and elevator-design rules [Rothenfluh et al., 1996]. Musen et al. [2000]
extended PROTE´GE´ and built a new version, called PROTE´GE´-2000.
Several researchers have studied techniques for extracting medical knowledge from
natural-language documents. In particular, Hahn and Schnattinger [1997a; 1997b; 1998]
built a parser for processing German medical texts on gastro-intestinal diseases. Romacker
and Hahn [2001] improved the parser and showed that the resulting accuracy of seman-
tic representations was between 80% and 93%; however, its effectiveness in constructing
knowledge bases was very low.
Researchers have also considered data-mining techniques for learning medical knowl-
edge from clinical databases [Cimino et al., 1988; Shusaku, 1998; Mendonc¸a and Cimino,
2000]. Although these techniques generated basic diagnosis rules, they allowed the correct
diagnosis only in 8% of the test cases.
The reader can find a more detailed review of the work on knowledge entry in the
book by Boose and Gains [1990], who described knowledge-acquisition tools not only for
medical systems but also for other applications. Ringland and Duce [1988] presented stan-
dard techniques for knowledge representation, including functional approaches and tempo-
ral reasoning. Price [1990] also reviewed general tools for knowledge representation and
acquisition.
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Chapter 3
Selection of Clinical Trials
Physicians at the Moffitt Cancer Center have about 150 clinical trials available for cancer
patients. They have identified criteria that determine a patient’s eligibility for each clinical
trial, and they use these criteria to select appropriate trials for eligible patients. Tradition-
ally, physicians have selected trials by a manual analysis of a patient’s data. The review of
resulting selections has shown that they usually do not check all clinical trials and occa-
sionally miss an appropriate trial.
To address this problem, Fletcher and her colleagues built a system for automatic
selection of clinical trials, and a knowledge base for breast cancer [Bhanja et al., 1998].
Their system prompted a clinician to enter the results of medical tests for a patient, and
identified appropriate trials. It selected the order of questions that minimized the expected
amount of data entry. For instance, if some question could reveal that a patient was not
eligible for any trial, the system asked it before the other questions. Experiments showed
that the system reduced the human effort involved in trial selection and helped to avoid
inaccuracies. Kokku has continued this work and added information about the costs of
medical tests and the pain levels of related procedures [Kokku et al., 2002b]. He has
developed a technique for finding the order of test procedures that reduces the expected
cost and pain.
We review Kokku’s system for selection of clinical trials. We begin with an example
of the selection process (Section 3.1), describe the main elements of the knowledge base
(Section 3.2), and explain heuristics for test ordering (Section 3.3).
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General information
1. The patient is female.
2. She is at most forty-five years old.
Mammogram: Cost is $150, pain level is 1
3. Cancer stage is either II or III.
4. Cancer is not invasive.
Electrocardiogram: Cost is $160, pain level is 1
5. The patient has no congenital heart disease.
6. The patient has no cardiac arrhythmias.
Biopsy: Cost is $200, pain level is 3
7. At most three lymph nodes have tumor cells.
8. All tumors are smaller than three centimeters.
Figure 3.1: Eligibility criteria for Clinical Trial A.
3.1 Example
In Figure 3.1, we give a simplified example of eligibility criteria for a certain clinical trial,
called Trial A. We can use this trial for young and middle-age women with a noninvasive
breast cancer at stage II or III. A patient is eligible if she has at most three affected lymph
nodes, all her tumors are smaller than three centimeters, and she has no heart problems.
When a clinician tests a patient’s eligibility for this trial, he has to order three medical
tests. To check Conditions 3 and 4, a clinician sends a patient for a mammogram, which is
almost painless and costs $150. If the patient meets these conditions, she needs an electro-
cardiogram, which is the next cheapest test. Finally, if she satisfies Conditions 5 and 6, the
clinician sends her for a biopsy, which is an expensive and painful procedure.
The system first prompts a clinician to enter the patient’s sex and age (Figure 3.2a).
If the patient satisfies the corresponding conditions, the system asks for the mammogram
results (Figure 3.2b), and the clinician orders a mammogram. Then, the system requests
the electrocardiogram (Figure 3.2c) and biopsy (Figure 3.2d).
If the clinician has information about some of the patient’s old tests, he may answer
the corresponding questions along with entering personal data, before the system selects
9
What is the patient’s sex? Female Male
What is the patient’s age?
(a) General questions.
What is the cancer stage? I II III IV
Does the patient have invasive cancer? Yes © No © Unknown ©
(b) Mammogram results.
Does the patient have congenital heart disease? Yes © No © Unknown ©
Does the patient have cardiac arrhythmias? Yes © No © Unknown ©
(c) Electrocardiogram results.
How many lymph nodes have tumor cells?
What is the greatest tumor diameter?
(d) Biopsy results.
Figure 3.2: Example questions. The system guides a clinician through a series of questions,
grouped by test procedures, and uses the answers to select appropriate clinical trials.
test procedures. For example, if he knows that the patient has invasive cancer, he may enter
it along with sex and age, and then the system immediately rejects Trial A.
In Figure 3.3, we give another example of eligibility criteria, and we refer to the
corresponding clinical trial as Trial B. If both trials are in the knowledge base, the system
can check whether a patient is eligible for either of them. First, it prompts the clinician
to enter the general information (Figure 3.4a), and then asks for the mammogram results,
which are relevant to both trials (Figure 3.4b). If the results satisfy the eligibility criteria for
Trial B, the system requests the liver-test data (Figure 3.4c), and then outputs the decision
for Trial B. To determine the eligibility for Trial A, it requests the electrocardiogram data
(Figure 3.4d). If the results satisfy the eligibility criteria, the system asks for the biopsy
data (Figure 3.4e) and then outputs the decision for Trial A.
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General information
1. The patient is female.
2. She is at least twenty-seven years old.
Mammogram: Cost is $150, pain level is 1
3. Cancer stage is III.
4. Cancer is not recurrent.
Liver test: Cost is $150, pain level is 1
5. The patient has no hepatitis B.
6. The patient has no liver infections.
Figure 3.3: Eligibility criteria for Clinical Trial B.
3.2 Knowledge Base
The system’s knowledge base includes questions, medical procedures, and logical expres-
sions that represent eligibility conditions.
3.2.1 Questions
The system supports three types of questions. The first type takes a yes/no response, the
second is a multiple choice, and the third requires a numeric answer. When the system asks
a yes/no question, it accepts one of three answers: YES, NO, or UNKNOWN. The user can
disable the unknown option for some questions; for example, we do not accept unknown for
the electrocardiogram results in Figure 3.4(d). When the clinician gets a multiple-choice
question, such as a cancer stage, he has to select one of the available answers (Figure 3.4b).
An answer to a numeric question is a real value, which must be within the legal range for
this question; for example, a patient’s age is between 0 and 150 (Figure 3.4a), and a tumor
diameter is between 0 and 25 centimeters (Figure 3.4e).
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What is the patient’s sex? Female Male
What is the patient’s age?
(a) General questions.
What is the cancer stage? I II III IV
Does the patient have invasive cancer? Yes © No © Unknown ©
Does the patient have recurrent cancer? Yes © No © Unknown ©
(b) Mammogram results, relevant to both trials.
Does the patient have hepatitis B? Yes © No © Unknown ©
Does the patient have liver infections? Yes © No © Unknown ©
(c) Liver-test results, relevant to Trial B.
Does the patient have congenital heart disease? Yes © No ©
Does the patient have cardiac arrhythmias? Yes © No ©
(d) Electrocardiogram results, relevant to Trial A.
How many lymph nodes have tumor cells?
What is the greatest tumor diameter?
(e) Biopsy results, relevant to Trial A.
Figure 3.4: Checking the eligibility for two clinical trials. The system begins with the questions
related to both trials.
3.2.2 Medical Tests
The description of a medical test includes the test name, dollar cost, estimated pain level,
and list of questions that can be answered based on the test results. For example, the
mammogram in Figure 3.1 has a cost of $150 and pain level of 1, and it provides data for
Criteria 3 and 4. Two different tests may answer the same question; for instance, both the
mammogram and the biopsy show the cancer stage.
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sex = FEMALE and sex = MALE or
age ∈ [0, 45] and age ∈ (45, 150] or
cancer-stage ∈ {II, III} and cancer-stage ∈ {I, IV} or
invasive-cancer = NO and invasive-cancer ∈ {YES, UNKNOWN} or
lymph-nodes ∈ [0, 3] and lymph-nodes ∈ (3, 100] or
tumor-diameter ∈ [0, 3] and tumor-diameter ∈ (3, 25] or
heart-disease = NO and heart-disease ∈ {YES, UNKNOWN} or
cardiac-arrhythmias = NO cardiac-arrhythmias ∈ {YES, UNKNOWN}
(a) Acceptance expression. (b) Rejection expression.
Figure 3.5: Logical expressions for the criteria in Figure 3.1. The acceptance expression represents
the eligibility conditions (a), whereas the rejection expression describes ineligible patients (b).
3.2.3 Eligibility Criteria
We encode eligibility for a clinical trial by a logical expression that does not have negations,
called the acceptance expression. It includes variables that represent the available data, as
well as equalities, inequalities, “set-element” relations, conjunctions, and disjunctions. For
example, we encode the criteria in Figure 3.1 by the expression given in Figure 3.5(a).
In addition, the system uses the logical complement of the eligibility criteria, called the
rejection expression, which also does not include negations (Figure 3.5b). It describes the
conditions that make a patient ineligible for the clinical trial.
The system collects data until it can determine which of the two expressions is TRUE.
For example, if the patient’s sex is MALE, then the rejection expression in Figure 3.5(b) is
TRUE, and the system immediately determines that this trial is inappropriate. On the other
hand, if the sex is FEMALE, and the other values are unknown, then neither expression is
TRUE, and the system has to ask more questions.
3.3 Order of Tests
When a clinician enters medical data for a patient, the system identifies all appropriate
trials. The total cost and pain level of the tests involved in the trial selection may depend on
their ordering. For instance, if we begin with the mammogram, and it shows that the cancer
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stage is I, then we can immediately reject the trial in Figure 3.1 and avoid more expensive
tests.
Kokku et al. [2002a; 2002b] have studied heuristics for ordering the tests; their heuris-
tics account for the cost and pain level of tests, the structure of acceptance and rejection
expressions, and the number of expressions that require each test. The heuristics use a dis-
junctive normal form of acceptance and rejection expressions; that is, each expression must
be a disjunction of conjunctions.
Kokku has defined the overall “payment” for medical tests as a linear combination of
their costs and pain levels; that is, if a patient needs n tests, the payment is
a ·
n∑
i=1
costi + b ·
n∑
i=1
paini.
A user sets the values of a and b, and the system chooses the order of questions that reduces
the expected payment. After getting the results of the first test, it re-evaluates the need for
other tests and revises their ordering. The choice of the first test is based on three criteria.
1. Cost and pain level of the test. The system gives preference to tests with smaller
payments. For example, it may start with the mammogram, which is cheaper and
less painful than the other two tests in Figure 3.1.
2. Number of clinical trials that require the test. When the system checks a patient’s
eligibility for several trials, it prefers tests that provide data for larger number of
trials. For example, if the electrocardiogram gives data for three trials, the system
may prefer it to the mammogram despite its higher cost.
3. Immediate decisions for some trials. If a test can lead to an immediate acceptance or
rejection of some trials, the system prefers it to other tests. For instance, if the liver
test shows that the patient has hepatitis B, the system can immediately reject Trial B.
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To select the first test, the system scores all required tests according to the three
criteria. It computes a linear combination of these three scores for every test, and chooses
the test with the highest score. Kokku et al. [2002b] have evaluated this strategy using
retrospective data for 187 patients at the Moffitt Cancer Center, and demonstrated that it
significantly reduces the cost.
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Chapter 4
Entering Eligibility Criteria
When Fletcher developed the initial system, she did not include an interface for adding
eligibility criteria, and a programmer had to encode the criteria in a specialized language.
We have designed a web-based interface for adding new criteria, which consists of two
main parts; the first part is for entering information about medical tests (Figure 4.1), and
the second is for specifying eligibility criteria (Figure 4.2).
The interface includes fifteen screens; three of them are “start screens,” which can
be reached directly from any other screen. For example, consider the “Modifying a test”
screen in Figure 4.3, which allows changing the test name, cost, and pain level. It has four
buttons at the bottom for moving to related screens, and three buttons on the left for moving
to the start screens.
We give an example of entering eligibility criteria (Section 4.1), describe the two main
parts of the interface (Sections 4.2 and 4.3), give algorithms for generating acceptance and
rejection expressions (Section 4.4), and present experiments on the effectiveness of the
interface (Section 4.5).
4.1 Example
Suppose that the user needs to enter the clinical trials in Figures 3.1 and 4.4, and the system
initially has no information about the related tests. The user has to describe the tests and
questions, and then specify the eligibility conditions. We assume that he first enters the
trial in Figure 3.1, and later adds the trial in Figure 4.4.
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Adding tests
Modifying a test
question
Adding a yes/no
question
Adding a numeric Deleting
questions
Adding a multiple-
choice question
Change the cost and pain
View all questions
Add a new question
View all questions
Delete questions
View all questions
Add a new test
View an old test
Add a new question
View all questions View all questions
Add a new question
Change the test name
(a) Tests and questions.
question
Adding a yes/no
choice question
Adding a multiple-
question
Adding a numeric
General information
Deleting
questions
Add a new question
View all questions
Delete questions
View all questions
Add a new question
View all questions View all questions
Add a new question
View all questions
(b) General questions.
Figure 4.1: Entering tests and questions. We show the screens by rectangles and transitions be-
tween them by arrows. The bold rectangles are the start screens.
Adding clinical trials
Initialize new criteria
Finalize criteria
View criteria
Selecting tests
Choose relevant tests
Choose questions
make a patient eligible
Specify answers that an eligibility expression
Arrange questions into
Selecting questions
Defining an expression
Figure 4.2: Entering eligibility criteria.
Figure 4.3: “Modifying a test” screen. The three buttons on the left are for moving to the start
screens; every screen in the system has these buttons.
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First, he uses the “Adding tests” screen to enter the new tests; we illustrate the entry
of two tests in Figure 4.5. Then, he enters the related questions; to enter questions for a
specific test, he selects the test and clicks “Modify” (Figure 4.6), which takes him to the
“Modifying a test” screen (Figure 4.7).
To add a question, the user clicks the appropriate button at the bottom (Figure 4.7)
and then types the question (Figure 4.8). For a multiple-choice question, he has to include
the answer options (Figure 4.8b); for a numeric question, he needs to specify the range of
allowed values (Figure 4.8c). If other tests provide data for the same question, the user has
to select all related tests in the lower box (Figure 4.8b). The newly added questions appear
on the “Modifying a test” screen (Figure 4.9).
After adding the questions for all tests, the user goes to the “Adding clinical tri-
als” screen, initializes a new trial (Figure 4.10), and selects it for adding eligibility condi-
tions. He gets the “Selecting tests” screen and chooses the tests related to the trial (Fig-
ure 4.11). Then, he selects relevant questions and the answers that make a patient eligible
(Figure 4.12).
Now suppose that the user needs to add the clinical trial in Figure 4.4. The new
eligibility conditions require a liver test, which is not in the knowledge base, and the user
has to add the information related to this test. Furthermore, he has to add the question
about recurrent cancer to the mammography test. After making these additions, he is ready
to enter the eligibility criteria.
Condition 5 includes a disjunction, which requires the “Combined question” option
at the bottom of the questions screen (Figure 4.12). The user checks the elements of the dis-
junctive question, marks the appropriate answers, and clicks “Combined question,” which
takes him to the screen for composing logical expressions (Figure 4.13). After entering
Condition 5, he adds the other criteria using the “Simple questions” option (Figure 4.12).
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General information
1. The patient is female.
2. She is at least twenty-seven years old.
Mammogram: Cost is $150, pain level is 1
3. Cancer stage is III.
4. Cancer is not recurrent.
5. Either
• the tumor is at least two centimeters, or
• the cancer is not invasive and
at least two lymph nodes have tumor cells.
Liver test: Cost is $150, pain level is 1
6. The patient has no hepatitis B.
7. The patient has no liver infections.
Figure 4.4: Eligibility criteria with a disjunctive condition.
(a) Mammography test.
(b) Biopsy test.
Figure 4.5: Adding new tests.
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Figure 4.6: Selecting a test for entering the related questions.
Figure 4.7: “Modifying a test” screen. The system has no information about related questions, and
the user clicks one of the bottom buttons for moving to a question-entry screen.
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(a) Yes/no question. (b) Multiple-choice question.
(c) Numeric question.
Figure 4.8: Adding new questions. The user types a question and answer options. If the question
is related to several tests, the user should check all these tests.
Figure 4.9: “Modifying a test” screen with a list of questions.
21
Figure 4.10: Adding a new clinical trial.
Figure 4.11: Choosing tests and question types.
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Figure 4.12: Selecting questions and answers. The user checks the questions for the current clinical
trial and marks the answers that satisfy the eligibility criteria.
Figure 4.13: Combining questions into a logical expression.
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4.2 Tests and Questions
We now describe the six-screen interface for adding tests and questions (Figure 4.1a). The
start screen allows viewing the available tests and defining new ones, whereas the other
screens are for modifying tests and adding related questions.
4.2.1 Adding Tests
We show the start screen in Figure 4.5; its left-hand side allows viewing questions and
going to a modification screen. If the user selects a test and clicks “View,” the system
shows the related questions at the bottom of the same screen (Figure 4.14). If he clicks
“Modify,” it displays the “Modifying a test” screen (Figure 4.7). The right-hand side of
the start screen allows adding a new test by specifying its name, cost, and pain level.
4.2.2 Modifying a Test
The test-modification screen shows the information about a specific test, which includes the
test name, cost, pain level, and related questions (Figure 4.9). The user can change the test
name, cost, and pain level by entering new values and clicking “Change.” The four bottom
buttons allow moving to the screens for adding new questions and deleting old questions.
4.2.3 Adding a Question
We show the screen for adding yes/no questions in Figure 4.8(a), multiple-choice questions
in Figure 4.8(b), and numeric questions in Figure 4.8(c). The user can enter a new question
for the current test, along with a set of allowed answers. If the question is also related to
other tests, the user has to mark them in the lower box (Figure 4.8b).
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4.2.4 Deleting Questions
This screen (Figure 4.15) is for removing old and incorrectly entered questions. The user
has to mark unwanted questions and click “Delete.”
4.2.5 General Information
The general questions include sex, age, and other personal data, collected without medical
tests. The mechanism for adding such questions consists of five screens (Figure 4.1b), and
the user adds general questions in the same way as test-related questions.
Figure 4.14: Viewing the questions for a specific test.
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4.3 Eligibility Conditions
We next describe the mechanism for entering eligibility criteria, which consists of four
screens (Figure 4.2).
4.3.1 Adding Clinical Trials
The start screen (Figure 4.16) allows the user to initialize a new clinical trial, view the
criteria for old trials, and finalize completed trials. The lower part of the screen is for ini-
tializing a new trial, which requires entering the trial’s name and unique number. The upper
part is a list of trials with unfinished eligibility criteria. The user can view the questions for
an unfinished trial by clicking “View,” and he can go to a modification screen by clicking
“Modify.” After completing the eligibility criteria, the user finalizes the trial by clicking
“Activate.” The list of finalized trials is in the middle of the screen; the user can view these
trials, but he cannot modify them.
4.3.2 Selecting Tests
If the user clicks “Modify” on the start screen, the system displays the test-selection screen
(Figure 4.11). The user then chooses related tests and question types, and clicks “Con-
tinue” to get the question list. For instance, if he chooses mammogram and biopsy on
the left, and the top two question types on the right, then he gets a list of all yes/no and
multiple-choice questions related to the mammogram and biopsy.
4.3.3 Selecting Questions
The next screen (Figure 4.12) allows the user to select specific questions and mark answers
that make a patient eligible. For a multiple-choice question, the user may specify several
eligibility options; for example, a patient may be eligible if her cancer stage is II or III. For
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a numeric question, the user has to specify a range of values; for example, a patient may
be eligible if her age is between 0 and 45 years. If the user clicks “Simple questions,” the
system generates a conjunction of the selected criteria. If the eligibility conditions involve
a more complex expression, the user has to click “Combined question,” which takes him
to the screen for composing logical expressions.
4.3.4 Defining an Expression
This screen (Figure 4.13) allows the user to arrange the selected questions into an expres-
sion that includes nested conjunctions and disjunctions; however, the system does not allow
negations.
4.4 Logical Expressions
When the user finalizes a clinical trial, the system combines the eligibility criteria into
an acceptance expression, and then generates the corresponding rejection expression. In
Figure 4.17, we give an algorithm that constructs the rejection expression by recursive
application of DeMorgan’s laws; the resulting expression does not include negations.
If the system uses the ordering heuristics described in Section 3.3, it has to convert the
acceptance and rejection expressions into a disjunctive normal form, that is, a disjunction of
conjunctions; we use a standard conversion algorithm [Kenneth, 1988; Crama and Hammer,
2001], summarized in Figure 4.18. For instance, if the eligibility criteria are as shown in
Figure 4.19(a), the system generates the acceptance expression in Figure 4.19(b) and the
rejection expression in Figure 4.19(c).
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Figure 4.15: Deleting two questions.
Figure 4.16: “Adding clinical trials” screen. It allows the user to add new trials (bottom part),
modify and finalize eligibility criteria (top), and view the finalized criteria (middle).
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Negate-Expression(bool-exp)
The input is a logical expression, bool-exp, which represents eligibility criteria.
Determine whether bool-exp is a conjunction, disjunction,
yes/no question, multiple-choice question, or numeric question.
Call the appropriate subroutine below and return the resulting expression.
Negate-Conjunction(bool-exp)
The input is a conjunctive expression; that is, bool-exp is “sub-exp and sub-exp and . . .”
New-Exps := ∅.
For every term sub-exp of the conjunction bool-exp:
New-Exps := New-Exps ∪ {Negate-Expression(sub-exp)}.
Return the disjunction of all terms in New-Exps.
Negate-Disjunction(bool-exp)
The input is a disjunctive expression; that is, bool-exp is “sub-exp or sub-exp or . . .”
New-Exps := ∅.
For every term sub-exp of the disjunction bool-exp:
New-Exps := New-Exps ∪ {Negate-Expression(sub-exp)}.
Return the conjunction of all terms in New-Exps.
Negate-Yes-No(bool-exp)
The input is a yes/no question.
If bool-exp is “Variable = YES,” then return “Variable ∈ {NO, UNKNOWN}.”
If bool-exp is “Variable = NO,” then return “Variable ∈ {YES, UNKNOWN}.”
If bool-exp is “Variable ∈ {YES, UNKNOWN},” then return “Variable = NO.”
If bool-exp is “Variable ∈ {NO, UNKNOWN},” then return “Variable = YES.”
Negate-Multiple-Choice(bool-exp)
The input is a multiple-choice question; that is, bool-exp is “Variable ∈ Option-Set.”
Let All-Options be the set of all answer options for Variable.
New-Options := All-Options − Option-Set.
(This set difference includes all answers that are not in Option-Set.)
Return “Variable ∈ New-Options.”
Negate-Numeric(bool-exp)
The input is a numeric question; that is, bool-exp is “Variable ∈ [Min, Max].”
Let “[Lower, Upper]” be the range of allowed values for Variable;
that is, the value of Variable is always between Lower and Upper.
If Min = Lower, then return “Variable ∈ (Max, Upper].”
If Max = Upper, then return “Variable ∈ [Lower, Min).”
Return “Variable ∈ [Lower, Min) ∪ (Max, Upper].”
Figure 4.17: Constructing a rejection expression. The Negate-Expression procedure inputs an
acceptance expression and recursively processes its subexpressions.
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Normalize(bool-exp)
The input is a logical expression, bool-exp; the output
is an equivalent expression in disjunctive normal form.
If bool-exp is an equality, inequality, or “set-element” test,
then return bool-exp.
If bool-exp is a disjunction sub-exp1 ∨ sub-exp2,
then norm-exp1 := Normalize(sub-exp1);
norm-exp2 := Normalize(sub-exp2);
return norm-exp1 ∨ norm-exp2.
If bool-exp is a conjunction sub-exp1 ∧ sub-exp2,
then norm-exp1 := Normalize(sub-exp1);
norm-exp2 := Normalize(sub-exp2);
return Merge(norm-exp1, norm-exp2).
Merge(norm-exp1 , norm-exp2)
The input is two logical expressions, norm-exp1 and norm-exp2, in disjunctive normal form;
the output is a disjunctive normal form of their conjunction, norm-exp1 ∧ norm-exp2.
New-Exps := 0.
For every term sub-exp1 of norm-exp1:
For every term sub-exp2 of norm-exp2:
New-Exps := New-Exps ∪ {sub-exp1 ∧ sub-exp2}.
Return the disjunction of all terms in New-Exps.
Figure 4.18: Converting an expression into a disjunctive normal form. The Normalize procedure
inputs an expression without negations, which represents acceptance or rejection conditions, and
generates an equivalent expression in disjunctive normal form.
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sex = FEMALE and
age ∈ [27, 150] and
cancer-stage = III and
recurrent = NO and
(tumor-size ∈ [2, 25] or
(invasive = NO and lymph-nodes ∈ [2, 100])) and
hepatitis = NO and
liver-infections = NO
(a) Eligibility criteria.


sex = FEMALE and
age ∈ [27, 150] and
cancer-stage = III and
recurrent = NO and
tumor-size ∈ [2, 25] and
hepatitis = NO and
liver-infections = NO


or


sex = FEMALE and
age ∈ [27, 150] and
cancer-stage = III and
recurrent = NO and
invasive = NO and
lymph-nodes ∈ [2, 100] and
hepatitis = NO and
liver-infections = NO


(b) Acceptance expression.
sex = MALE or
age ∈ [0, 27) or
cancer-stage ∈ {I, II, IV} or
recurrent ∈ {YES, UNKNOWN} or
(tumor-size ∈ [0, 2) and invasive ∈ {YES, UNKNOWN}) or
(tumor-size ∈ [0, 2) and lymph-nodes ∈ [0, 2)) or
hepatitis ∈ {YES, UNKNOWN} or
liver-infections ∈ {YES, UNKNOWN}
(c) Rejection expression.
Figure 4.19: Acceptance and rejection expressions for the eligibility criteria in Figure 4.4. We
represent both expressions as disjunctive normal forms without negations.
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4.5 Entry Time
To evaluate the interface, we have run experiments with seven novice users. All participants
have been undergraduate students, who had no prior experience with the interface. First,
every user has entered four sets of medical tests; each set has included three tests and ten
questions. Then, each user has added eligibility expressions for ten breast-cancer trials
used at the Moffitt Cancer Center; the number of questions in an eligibility expression has
varied from ten to thirty-five.
We have measured the entry time for each test set and each clinical trial (Tables 4.1 and 4.2).
We show the mean time for every test set in Figure 4.20(left), and the time per question for
the same sets in Figure 4.20(right). All users have entered the test sets in the same order,
from 1 to 4; since they had no prior experience, their performance has improved during the
experiment. In Figure 4.21, we give similar graphs for the entry of clinical trials.
In Figure 4.22, we plot the dependency of the entry time on the size of an eligibility
expression, for the eight trials entered after the initial learning period. The results suggest
that the time linearly depends on the number of questions, which means that the time per
question does not depend on the complexity of an expression.
The experiments have shown that novices can efficiently use the interface; they quickly
learn its full functionality, and their learning curve flattens after about an hour. The average
time per question is 31 seconds for the entry of medical tests and 37 seconds for eligibility
criteria, which means that a user can enter all breast-cancer trials used at Moffitt in about
nine hours. On the other hand, coding the same trials without the interface is projected to
take seven weeks of full-time work.
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Table 4.1: Entry time for medical tests and related questions. We give the times for seven users,
who have entered four sets of tests. Every set includes three tests and ten questions.
Num. of Entry time (seconds)
a test set User A User B User C User D User E User F User G Mean
1 575 726 575 874 412 420 468 579
2 348 505 375 430 383 300 345 390
3 339 430 345 338 323 275 321 339
4 303 355 382 302 336 205 314 316
Table 4.2: Entry time for eligibility criteria. We show the results for seven users; each user has
constructed eligibility expressions for ten clinical trials. The number of questions in an expression
varies from ten to thirty-five.
Num. of Num. of Entry time (seconds)
a trial questions User A User B User C User D User E User F User G Mean
1 10 1380 590 406 566 970 420 563 586
2 12 225 322 580 700 640 437 475 526
3 15 443 466 570 340 775 300 507 493
4 18 622 443 812 712 1080 497 570 686
5 21 630 602 746 722 1230 828 760 815
6 27 683 597 700 612 972 882 579 724
7 28 753 742 1032 880 995 950 889 915
8 29 763 634 860 722 1020 763 865 811
9 30 431 561 623 460 765 443 605 576
10 35 1168 900 1265 1085 1555 1007 1160 1162
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Figure 4.20: Entry time for medical test sets (left) and the mean time per question for each set
(right). We plot the average performance (dashed lines) and the time of the fastest and slowest users
(vertical bars).
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Figure 4.21: Entry time for eligibility criteria. We show the average time for each clinical trial and
the corresponding time per question (dashed lines), along with the performance of the fastest and
slowest users (vertical bars).
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Figure 4.22: Dependency of the time on the number of questions in an eligibility expression. We
plot the time of entering eligibility expressions (left) and the corresponding time per question (right).
The results show that the time per question does not depend on the complexity of an expression.
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Chapter 5
Concluding Remarks
We have developed knowledge-acquisition tools for an expert system that selects clinical
trials for cancer patients. We have described the representation of selection criteria and a
web-based interface for adding new trials. Although cancer research at Moffitt has pro-
vided the motivation for this work, the developed tools are not limited to cancer, and we
can use them to enter selection criteria for clinical trials related to other diseases.
The experiments have shown that a user can enter a clinical trial in ten to twenty min-
utes, whereas programming the same knowledge without the interface takes about twenty
hours (personal communication with Kokku). Novices can readily use the interface without
prior instructions, and they reach their full speed after about an hour.
The experiments have also revealed several limitations of the developed tools, and
addressing them may be a subject of future work. First, the expert system does not esti-
mate probabilities of medical-test results. We conjecture that integration of probabilistic
methods with the current heuristics may further reduce the cost of selected tests. Second,
the system does not parse the text of questions, and it cannot recognize identical or related
questions. If a user accidently enters the same question twice, the system will treat it as two
different questions. Third, the interface does not allow a user to encode logical relation-
ships among questions. For example, we cannot specify that a post-menopausal woman is
never pregnant. If the knowledge base includes menopause and pregnancy questions, the
system may ask about pregnancy even after learning that a patient is post-menopausal.
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